• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tevogen Bio Holdings Inc. - Common Stock (NQ:TVGN)

0.9999 +0.0106 (+1.07%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 385,489
Open 1.000
Bid (Size) 1.000 (1)
Ask (Size) 1.020 (24)
Prev. Close 0.9893
Today's Range 0.9750 - 1.030
52wk Range 0.2556 - 3.090
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders
Today 15:57 EDT
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio to Accept $1 Million Additional Grant Funding for AI Expansion
Today 15:30 EDT
From Tevogen Bio Inc
Via GlobeNewswire

Performance

YTD
-5.7%
-5.7%
1 Month
-20.0%
-20.0%
3 Month
-1.0%
-1.0%
6 Month
-32.9%
-32.9%
1 Year
+61.5%
+61.5%

More News

Read More
Tevogen Highlights 74% Insider Ownership, Reinforcing Long-Term Vision
July 30, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen.AI Applauds U.S. Government’s AI Action Plan; Reaffirms Commitment to Accelerating AI Innovation in Healthcare
July 28, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides
July 18, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Signs Letter of Intent for New In-House Cell Therapy Manufacturing Facility
July 17, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen.AI Targets Faster Time-to-Market with AI-Powered Patient Matching Following PredicTcell™ Alpha Launch
July 16, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen.AI Builds Alpha Version of PredicTcell™ Model with Microsoft and Databricks; Observes Drastic Time Reduction in Target Analysis Translating to Potential Savings of Billions in Drug Development Costs
July 14, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen’s New Headquarters, Fully Funded by CEO, Centralizes R&D and AI Teams to Accelerate Innovation
July 10, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen CEO Contributes to Build-Out and First-Year Operations of New Headquarters
June 30, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Updates on Development of EBV-Specific T Cell Therapy with Support from AI-Powered Target Discovery
June 18, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Expands Headquarters Amid Growth of AI and Generics & Biosimilars Initiatives
June 09, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Details its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy with Microsoft and Databricks Partnerships
May 30, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio Plans to Expand Specialty Care Pipeline to Include Patients 65+, Building on Previous Forecast of Nearly $1 Billion in Launch-Year; Updated rNPV to Follow
May 23, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen to Update on Robust Portfolio Assets, Business Expansion, Partnerships, Limited Tradable Float, High Insider Ownership and Strong Investor Confidence Ahead of June 23 Annual Meeting
May 22, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation
May 12, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest
May 02, 2025
From Tevogen Bio Inc
Via GlobeNewswire
CD8 Technology Signs Letter of Intent for Tevogen Bio’s In-House Manufacturing Facility, Marking First Phase of Up to $50 Million Commitment
April 30, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Informs Public Shareholders About DRS Accounts And Differences to Brokerage Accounts
April 29, 2025
From Tevogen Bio Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 29, 2025
Via Benzinga
Why Leggett & Platt Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
April 29, 2025
Via Benzinga
Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald
April 29, 2025
From Tevogen Bio Inc
Via GlobeNewswire
Curious about the stocks that are showing activity after the closing bell on Monday?
April 28, 2025
Via Chartmill
Tevogen Bio Holdings Stock Is Soaring After Hours: What's Going On?
April 28, 2025
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
April 28, 2025
Via Benzinga

Frequently Asked Questions

Is Tevogen Bio Holdings Inc. - Common Stock publicly traded?
Yes, Tevogen Bio Holdings Inc. - Common Stock is publicly traded.
What exchange does Tevogen Bio Holdings Inc. - Common Stock trade on?
Tevogen Bio Holdings Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tevogen Bio Holdings Inc. - Common Stock?
The ticker symbol for Tevogen Bio Holdings Inc. - Common Stock is TVGN on the Nasdaq Stock Market
What is the current price of Tevogen Bio Holdings Inc. - Common Stock?
The current price of Tevogen Bio Holdings Inc. - Common Stock is 0.9999
When was Tevogen Bio Holdings Inc. - Common Stock last traded?
The last trade of Tevogen Bio Holdings Inc. - Common Stock was at 08/01/25 04:00 PM ET
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap